Penumbra, Inc. to Present at Upcoming Investor Conferences
Penumbra, Inc. (NYSE: PEN), located in Alameda, California, has announced participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Penumbra, Inc. (NYSE: PEN), located in Alameda, California, has announced participation in two upcoming investor conferences. The company will present at the 2022 Wells Fargo Securities Healthcare Conference on September 7, 2022, at 9:45 AM ET and at the Morgan Stanley Global Healthcare Conference on September 13, 2022, at 12:20 PM ET. Webcasts will be available on their investor website for two weeks following the events.
Details
News Market Reaction – PEN
The recorded move for PEN in the trading session of this news was +4.88%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALAMEDA, Calif., Aug. 24, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following investor conferences on the dates and times listed below:
Event: | 2022 Wells Fargo Securities Healthcare Conference |
Date: | Wednesday, September 7, 2022 |
Time: | 9:45am ET / 6:45am PT |
Event: | Morgan Stanley Global Healthcare Conference 2022 |
Date: | Tuesday, September 13, 2022 |
Time: | 12:20pm ET / 9:20am PT |
Webcasts of the presentations will be available by visiting the investors' section of the company's website at www.penumbrainc.com. The webcasts will be available on the company's website for at least two weeks following the event.
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-upcoming-investor-conferences-301607299.html
SOURCE Penumbra, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.